Income statement
USD
Annual
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 87K | 155K | 373K | 1M | 347K |
| Gross Profit | -195K | -52K | 11K | 157K | 99K |
| Operating Income | -4M | -5M | -4M | -4M | -6M |
| EBITDA | -3M | -7M | -4M | -4M | -5M |
| Net Income | -4M | -4M | -3M | -4M | -6M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.00001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Zecotek Photonics Inc. (ZMSPF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -44.3%, EPS growth of +8.8%, a dividend yield of 0.0%. What stands out right now is revenue -44.3%, EPS +8.8%, free cash flow -21.6% with operating margin -4222.1% and ROIC 4951.3%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ZMSPF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ZMSPF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ZMSPF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ZMSPF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$347.1K
-69.6% YoY
FY Net Income
-$5.5M
-37.0% YoY
Free Cash Flow
-$3.3K
+99.9% YoY
Revenue Growth
-44.3%
EPS Growth
+8.8%
Gross Margin
-225.5%
Net Margin
-4063.0%
Income statement
USD
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Revenue | 87K | 155K | 373K | 1M | 347K |
| Gross Profit | -195K | -52K | 11K | 157K | 99K |
| Operating Income | -4M | -5M | -4M | -4M | -6M |
| EBITDA | -3M | -7M | -4M | -4M | -5M |
| Net Income | -4M | -4M | -3M | -4M | -6M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|
| Cash & Equivalents | 459K | 2M | 690K | 185K | 266K |
| Total Assets | 3M | 3M | 843K | 616K | 991K |
| Total Liabilities | 6M | 3M | 6M | 6M | 5M |
| Shareholder Equity | -6M | -3M | -5M | -6M | -4M |
| Total Debt | 3M | 0 | 16K | 38K | 0 |
| Net Debt | 3M | -2M | -674K | -147K | -266K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3K
+99.9% YoY
Capital Expenditures
43
+98.4% YoY
Free Cash Flow
3K
+99.9% YoY
Key ratios
Gross Margin
-225.5%
Operating Margin
-4222.1%
Net Margin
-4063.0%
ROE
82.4%
Debt / Equity
-0.54x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.